BUZZ-ALX Oncology 因早期乳腺癌试验显示前景而上涨

路透中文
Jan 30
BUZZ-<a href="https://laohu8.com/S/ALXO">ALX Oncology</a> 因早期乳腺癌试验显示前景而上涨

1月30日 - ** 药物开发商 ALX Oncology ALXO.O 股价盘前上涨 4.46% 至 1.64 美元

** 公司称 (link) 实验性抗癌药物 evorpacept 在晚期乳腺癌患者的早期试验中取得了令人鼓舞的结果

** 公司称,9名患者中有5名肿瘤缩小;CD47水平较高的患者治疗效果更好,CD47是一种帮助癌症逃避免疫系统的蛋白质。

** 公司称癌症恶化前的中位时间为 7.4 个月

** 2025 年股价下跌约 32%

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10